Objectives Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) are associated with improved ...

Adverse drug effects commonly occur in patients with rheumatologic diseases, most of whom take multiple medications to ...

Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

Oral findings are usually limited to type 1 diabetes. Problems include periodontal disease, delayed wound healing, and an increased risk of infection. Enlargement of the parotid glands may also be ...

Heart attacks in young adults are twice as likely to be fatal in those with inflammatory conditions like psoriasis, lupus or rheumatoid arthritis, suggest the findings of a new study. The study was ...

Researchers at Helmholtz Munich, the Ludwig Maximilians University Munich (LMU) and collaborating institutions have developed ...

SAN DIEGO — CD19-directed chimeric antigen receptor (CAR) T-cell therapy, which has transformed the treatment landscape for B-cell malignancies, is now showing great promise in at least three distinct ...

A diagnosis of advanced systemic mastocytosis (advSM), a rare blood disorder in which too many mast cells accumulate in various parts of the body, can cause a range of strong emotions. AdvSM sometimes ...

New Cosentyx® (secukinumab) data from REPLENISH, largest ever global Phase III trial in polymyalgia rheumatica, to be ...